Clinical Trial Update: A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

View source ↗

Summary

Memorial Sloan Kettering Cancer Center is conducting a study to collect information about using redifferentiating medications as standard treatment for thyroid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thyroid Cancer, Thyroid | Status: RECRUITING